Pros
Interesting time in the market for oncology data analytics Good work life balance
Cons
Very dysfunctional executive team that does not get along; weak CEO (former banker) who lacks experience in healthcare & tech industry and struggles to establish strategy and execute on product roadmap Key talent in Product, BD and Engineering have left; large amounts of turnover (over 30%) at highest level of organization (over 8 Exec/SVP/VP in the last 12 months) due to lack of strategy, defined products and toxic culture Highest turnover in BD due to difficulty selling products that are far from market ready; mgt does not honor bonus commitments Poorly resourced product/engineering team due to insufficient resourcing, resulting in ill-defined, immature and unscalable products Toxic culture created from very top heavy dysfunctional executive team, making day to day work a miserable... Overall, a lot of smoke and mirrors....